STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
In accordance with the resolution passed by Elekta’s (EKTA-B.ST) Annual
General Meeting on September 1, 2016, the Chairman of the Board has
contacted the company’s four largest shareholders in terms of votes, in
addition to the shareholder or shareholders represented by the Chairman
himself, each of whom expressed an interest in participating in the
Nomination Committee, and appointed one member (see below) to form
Elekta’s Nomination Committee together with the Chairman of the Board.
The procedure is described in detail in the notice of the 2016 Annual
Nomination Committee members:
Laurent Leksell, in his capacity as Chairman of the Board of Elekta
and representing his own and related parties’ holdings
Åsa Nisell, appointed by Swedbank Robur funds
Per Colleen, appointed by the Fourth Swedish National Pension Fund
Magnus Henjeby, appointed by Nordea Investment funds
Tomas Flodén, appointed by AMF Försäkring & Fonder
The Nomination Committee will appoint one of its members as Chairman.
The Nomination Committee is to present proposals for resolutions by the
2017 Annual General Meeting of Shareholders in relation to the
following: Chairman of the Annual General Meeting of Shareholders,
Chairman of the Board of Directors and other members of the Board of
Directors, Fees to the Board of Directors broken down into amounts for
the Chairman of the Board of Directors, other members of the Board of
Directors and members of the Board of Directors’ committees, External
auditor and fees to the auditor, and where deemed necessary, proposal to
amend the procedure for the Nomination Committee.
Shareholders wishing to submit proposals to Elekta’s Nomination
Committee can do so by e-mail to email@example.com
or by letter to:
Elekta AB, Nomination Committee
SE-103 93 Stockholm
This is information that Elekta AB (publ) is obliged to make public
pursuant to the EU Market Abuse Regulation. The information was
submitted for publication at 07:30 CET on November 9, 2016.
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning
systems for radiation therapy, radiosurgery and brachytherapy, as well
as workflow enhancing software systems across the spectrum of cancer
care. Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to
both health care providers and patients, Elekta aims to improve, prolong
and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over
6,000 hospitals worldwide. Elekta employs around 3,600 employees
globally. The corporate headquarters is located in Stockholm, Sweden,
and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
This information was brought to you by Cision http://news.cision.com